Lupin ties-up with Mylan to commercialize Enbrel biosimilar
Lupin has associated with Mylan to commercialize Enbrel biosimilar. Enbrel is a TNF-inhibitori suggested to treat certain autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, plaque psoriasis and...
